Las Vegas, NV -- (SBWIRE) -- 11/18/2013 -- EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more .EquityObserver.com issues a special report on the following stocks: New Residential Investment Corp (NYSE:NRZ), VOXELJET AG (NYSE:VJET), MannKind Corporation (NASDAQ:MNKD), Meritor Inc (NYSE:MTOR)
New Residential Investment Corp (NYSE:NRZ) managed to keep its fall at -0.33% on above-normal volume of 3.60M shares. The stock settled at $6.07 after floating in a range of $5.94 to $6.10. Its latest price has reached market capitalization of $1.54 billion. Its 52-week range has been $5.83 to $7.29. New Residential Investment Corp., incorporated on September 26, 2013, is a real estate investment trust. The Company focuses on investing in, and actively managing, investments related to residential real estate.
Has NRZ Found The Bottom and Ready To Move Up? Find Out Here
VOXELJET AG (NYSE:VJET) traded up on a volume of 3.56 million, higher than its standard daily volume. Shares have gained 12.58% to $58.99. Over the last twelve months, the stock has gained 77.73% and faced a worst price of $19.30. voxeljet AG provides three-dimensional (3D) printers and on-demand parts services. Its 3D printers employ a powder binding additive manufacturing technology to produce parts using various material sets.
For How Long VJET’s Gloss will Attract Investors? Find out via this report
MannKind Corporation (NASDAQ:MNKD) settled -0.79% lower at $5.05 on below -normal volume of 3.55M shares during the last trading day. The stock has its 12-month high at $8.70 and 52-week low price was $1.88. It traded in a range of $4.98 to $5.16 during the last trading day. MannKind Corporation (MannKind) is a development-stage biopharmaceutical company. The Company is focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes and cancer. The Company’s product candidate, AFREZZA (insulin human) inhalation powder, is insulin that is in late-stage clinical investigation for the treatment of adults with type I or type II diabetes for the control of hyperglycemia.
Will MNKD Get Buyers Even After The Recent Rally? Find Out Here
In the last trading session, Meritor Inc (NYSE:MTOR) was up on high volume, trading at a volume of 3.58M versus its average daily volume of 1.70 million shares. At $7.03, the stock has attained market capitalization of 685.05 million. Meritor, Inc. (Meritor) is a global supplier of a range of integrated systems and components to original equipment manufacturers (OEMs) and the aftermarket for the commercial vehicle, transportation and industrial sectors.
Will MTOR Continue To Move Higher? Find Out Here
About Equity Observer:
Equity Observer delivers intra-day insights into the equities, tech and investment world. The website is a window into what’s going on in the business world and why.
EquityObserver.com covers the breadth of the markets, from stocks and bonds to ETFs, options, emerging markets, activities at the Fed and more.
The disclaimer is to be read and fully understood before using our site, or joining our email list.
http://www.equityobserver.com/ has a no tolerance spam policy; we will not sell or re-distribute your email to any 3rd party. A If applicable, please also unsubscribe from the newsletter using the link at the bottom of the email if you no longer wish to receive our emails. We only send our newsletters to opt-in members.
PLEASE NOTE WELL: The http://www.equityobserver.com/" rel="nofollow" href="http://www.equityobserver.com/"> http://www.equityobserver.com/>
Employees and contributors are NOT registered as an Investment Adviser in any jurisdiction whatsoever.
Read Full Disclaimerat: http://www.equityobserver.com/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)